320 related articles for article (PubMed ID: 28434837)
1. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
2. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
[TBL] [Abstract][Full Text] [Related]
4. Diabetes-related factors and abdominal aortic aneurysm events: the Atherosclerotic Risk in Communities Study.
Kubota Y; Folsom AR; Pankow JS; Wagenknecht LE; Tang W
Ann Epidemiol; 2018 Feb; 28(2):102-106.e1. PubMed ID: 29277551
[TBL] [Abstract][Full Text] [Related]
5. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease.
Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
7. Impact of fatty liver disease and metabolic syndrome on incident type 2 diabetes; a population based cohort study.
Mitsuhashi K; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukuda T; Fukui M
Endocr J; 2017 Nov; 64(11):1105-1114. PubMed ID: 28867686
[TBL] [Abstract][Full Text] [Related]
8. Fasting plasma glucose and incidence of diabetes --- implication for the threshold for impaired fasting glucose: results from the population-based Omiya MA cohort study.
Kato M; Noda M; Suga H; Matsumoto M; Kanazawa Y
J Atheroscler Thromb; 2009; 16(6):857-61. PubMed ID: 20032586
[TBL] [Abstract][Full Text] [Related]
9. Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study.
Ahn HJ; Han KD; Choi EK; Jung JH; Kwon S; Lee SR; Oh S; Lip GYH
Cardiovasc Diabetol; 2021 Jan; 20(1):20. PubMed ID: 33468142
[TBL] [Abstract][Full Text] [Related]
10. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
Bombelli M; Quarti-Trevano F; Tadic M; Facchetti R; Cuspidi C; Mancia G; Grassi G
J Hypertens; 2018 Jul; 36(7):1492-1498. PubMed ID: 29543626
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus.
Cho NH; Ahn CH; Moon JH; Kwak SH; Choi SH; Lim S; Park KS; Metzger BE; Jang HC
Medicine (Baltimore); 2016 Aug; 95(35):e4582. PubMed ID: 27583868
[TBL] [Abstract][Full Text] [Related]
12. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study.
Cugati S; Wang JJ; Rochtchina E; Mitchell P
Med J Aust; 2007 Feb; 186(3):131-5. PubMed ID: 17309402
[TBL] [Abstract][Full Text] [Related]
13. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
14. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
Kokubo Y; Okamura T; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Furukawa Y; Kamide K; Kawanishi K; Okayama A; Yoshimasa Y
Hypertens Res; 2010 Dec; 33(12):1238-43. PubMed ID: 20927111
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the impact of 3-year status changes of metabolic syndrome and its components on incident type 2 diabetes mellitus: a decade of follow-up in the Tehran Lipid and Glucose Study.
Hadaegh F; Abdi A; Kohansal K; Hadaegh P; Azizi F; Tohidi M
Front Endocrinol (Lausanne); 2023; 14():1164771. PubMed ID: 37305040
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Cardiometabolic Health as Midlife Women Transition to Menopause: A Prospective Multiethnic Study.
Ward E; Gold EB; Johnson WO; Ding F; Chang PY; Song P; El Khoudary SR; Karvonen-Gutierrez C; Ylitalo KR; Lee JS
J Clin Endocrinol Metab; 2019 May; 104(5):1404-1412. PubMed ID: 30365014
[TBL] [Abstract][Full Text] [Related]
19. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.
Stein PK; Barzilay JI; Domitrovich PP; Chaves PM; Gottdiener JS; Heckbert SR; Kronmal RA
Diabet Med; 2007 Aug; 24(8):855-63. PubMed ID: 17403115
[TBL] [Abstract][Full Text] [Related]
20. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
de Vegt F; Dekker JM; Jager A; Hienkens E; Kostense PJ; Stehouwer CD; Nijpels G; Bouter LM; Heine RJ
JAMA; 2001 Apr; 285(16):2109-13. PubMed ID: 11311100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
